Australia & New Zealand Stem Cell Market Forecast 2022-2028
Market Report I 2022-09-15 I 105 Pages I Inkwood Research
KEY FINDINGS
The Australia & New Zealand stem cell market is anticipated to rise with a CAGR of 10.50% over the estimated period. While the base year considered for the market study is 2021, the forecast years are from 2022 to 2028. The market growth of the country is driven by key factors such as increasing healthcare expenditure as well as favorable government support.
MARKET INSIGHTS
In 2019, the University of Melbourne and Stem Cells Australia was granted $104.65 million by the federal government for congenital heart diseases, stroke, dementia, blindness, and kidney diseases. Moreover, they also received $2.09 million for the advancement of stem cell research directed toward novel treatments in the year 2018. As a result, favorable government support and assistance for both firms and universities play an essential role in positively influencing the country's market growth.
On the other hand, the public health system in New Zealand has been providing stem cell bone marrow transplants for several years, especially for patients with cancer. In addition, a collection of private clinics has also been established in the country. These medical facilities offer stem cell treatments to patients suffering from various conditions, such as joint problems, auto-immune diseases, sports injuries, and neurological problems. Hence, owing to the aforementioned factors, the stem cell market in Australia & New Zealand is anticipated to progress at a steady rate over the forecasted years.
COMPETITIVE INSIGHTS
Key companies operating in the market include Corning Inc, Merck KGaA (Sigma Aldrich), GE Healthcare, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON STEM CELL MARKET
3.2. KEY MARKET TRENDS
3.3. PESTLE ANALYSIS
3.4. PORTER'S FIVE FORCES ANALYSIS
3.4.1. BUYERS POWER
3.4.2. SUPPLIERS POWER
3.4.3. SUBSTITUTION
3.4.4. NEW ENTRANTS
3.4.5. INDUSTRY RIVALRY
3.5. OPPORTUNITY MATRIX
3.6. VENDOR LANDSCAPE
3.7. VALUE CHAIN ANALYSIS
3.8. KEY BUYING CRITERIA
3.8.1. PRICE
3.8.2. EFFICACY
3.8.3. APPLICATION AND EFFECTIVENESS
3.8.4. ACCURACY
3.9. REGULATORY FRAMEWORK
4. MARKET BY THERAPEUTIC APPLICATION
4.1. ORTHOPEDIC TREATMENTS
4.2. INJURIES & WOUNDS
4.3. ONCOLOGY DISORDERS
4.4. CARDIOVASCULAR DISORDERS
4.5. NEUROLOGICAL DISORDERS
4.6. DIABETES
4.7. OTHER THERAPEUTIC APPLICATIONS
5. MARKET BY PRODUCT
5.1. ADULT STEM CELL
5.1.1. HEMATOPOIETIC STEM CELL
5.1.2. NEURAL STEM CELL
5.1.3. UMBILICAL CORD STEM CELL
5.1.4. MESENCHYMAL STEM CELL
5.1.5. DENTAL STEM CELL
5.2. HUMAN EMBRYONIC STEM CELL
5.3. PLURIPOTENT
5.4. MOUSE/RAT NEURAL
6. MARKET BY TECHNOLOGY
6.1. CELL ACQUISITION
6.1.1. BONE MARROW HARVEST
6.1.2. UMBILICAL CORD
6.1.3. APHERESIS
6.2. CELL PRODUCTION
6.2.1. THERAPEUTIC CLONING
6.2.2. IN VITRO FERTILIZATION (IVF)
6.2.3. CELL CULTURE
6.2.4. ISOLATION
6.3. CRYOPRESERVATION
6.4. EXPANSION & SUB-CULTURE
7. MARKET BY APPLICATION
7.1. REGENERATIVE MEDICINE
7.2. DRUG DISCOVERY AND DEVELOPMENT
8. MARKET BY TREATMENT TYPE
8.1. ALLOGENEIC STEM CELL THERAPY
8.2. AUTOLOGIC STEM CELL THERAPY
8.3. SYNGENEIC STEM CELL THERAPY
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. ACQUISITIONS
9.1.2. PARTNERSHIPS
9.2. COMPANY PROFILES
9.2.1. CORNING INC
9.2.2. GE HEALTHCARE
9.2.3. MERCK KGAA (SIGMA ALDRICH)
9.2.4. QIAGEN
9.2.5. SMITH+NEPHEW PLC
9.2.6. TAKARA HOLDINGS INC
9.2.7. THERMO FISHER SCIENTIFIC INC
LIST OF TABLES
TABLE 1: AUSTRALIA & NEW ZEALAND - COUNTRY SNAPSHOT
TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 6: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 8: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 10: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 12: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 14: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 16: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 18: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 20: LIST OF ACQUISITIONS
TABLE 21: LIST OF PARTNERSHIPS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: STEM CELL SCREENING STRATEGIES AND THEIR POTENTIAL APPLICATION
FIGURE 3: PESTLE ANALYSIS
FIGURE 4: PORTER'S FIVE FORCES ANALYSIS
FIGURE 5: OPPORTUNITY MATRIX
FIGURE 6: VENDOR LANDSCAPE
FIGURE 7: VALUE CHAIN ANALYSIS
FIGURE 8: KEY BUYING CRITERIA
FIGURE 9: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021
FIGURE 10: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2022-2028 (IN $ MILLION)
FIGURE 11: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY INJURIES & WOUNDS, 2022-2028 (IN $ MILLION)
FIGURE 12: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 13: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 14: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2022-2028 (IN $ MILLION)
FIGURE 15: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY DIABETES, 2022-2028 (IN $ MILLION)
FIGURE 16: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 17: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 18: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ADULT STEM CELL MARKET, 2022-2028 (IN $ MILLION)
FIGURE 19: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY ADULT STEM CELL, IN 2021
FIGURE 20: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL MARKET, 2022-2028 (IN $ MILLION)
FIGURE 21: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY NEURAL STEM CELL MARKET, 2022-2028 (IN $ MILLION)
FIGURE 22: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY UMBILICAL CORD STEM CELL MARKET, 2022-2028 (IN $ MILLION)
FIGURE 23: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY MESENCHYMAL STEM CELL MARKET, 2022-2028 (IN $ MILLION)
FIGURE 24: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY DENTAL STEM CELL MARKET, 2022-2028 (IN $ MILLION)
FIGURE 25: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2022-2028 (IN $ MILLION)
FIGURE 26: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY PLURIPOTENT, 2022-2028 (IN $ MILLION)
FIGURE 27: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2022-2028 (IN $ MILLION)
FIGURE 28: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 29: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL ACQUISITION, 2022-2028 (IN $ MILLION)
FIGURE 30: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY CELL ACQUISITION, IN 2021
FIGURE 31: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY BONE MARROW HARVEST, 2022-2028 (IN $ MILLION)
FIGURE 32: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY UMBILICAL CORD, 2022-2028 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY APHERESIS, 2022-2028 (IN $ MILLION)
FIGURE 34: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL PRODUCTION, 2022-2028 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY CELL PRODUCTION, IN 2021
FIGURE 36: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY THERAPEUTIC CLONING, 2022-2028 (IN $ MILLION)
FIGURE 37: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY IN VITRO FERTILIZATION (IVF), 2022-2028 (IN $ MILLION)
FIGURE 38: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CELL CULTURE, 2022-2028 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ISOLATION, 2022-2028 (IN $ MILLION)
FIGURE 40: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY CRYOPRESERVATION, 2022-2028 (IN $ MILLION)
FIGURE 41: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY EXPANSION & SUB-CULTURE, 2022-2028 (IN $ MILLION)
FIGURE 42: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 43: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2022-2028 (IN $ MILLION)
FIGURE 44: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2022-2028 (IN $ MILLION)
FIGURE 45: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, GROWTH POTENTIAL, BY TREATMENT TYPE, IN 2021
FIGURE 46: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2022-2028 (IN $ MILLION)
FIGURE 47: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2022-2028 (IN $ MILLION)
FIGURE 48: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2022-2028 (IN $ MILLION)
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.